Back to top

Image: Bigstock

New Strong Buy Stocks for September 27th

Read MoreHide Full Article

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

Trinseo S.A. (TSE - Free Report) : This materials company has seen the Zacks Consensus Estimate for its current year earnings increasing almost 3% over the last 60 days.

Trinseo S.A. Price and Consensus

 

Trinseo S.A. Price and Consensus

Trinseo S.A. price-consensus-chart | Trinseo S.A. Quote

Honda Motor Co., Ltd. (HMC - Free Report) : This company that develops, manufactures, and distributes motorcycles, automobiles, power products, and other products has seen the Zacks Consensus Estimate for its current year earnings increasing 3.2% over the last 60 days.

First Mid-Illinois Bancshares, Inc. (FMBH - Free Report) : This company that provides community banking products and services has seen the Zacks Consensus Estimate for its current year earnings increasing 3.7% over the last 60 days.

First Mid-Illinois Bancshares, Inc. Price and Consensus

 

First Mid-Illinois Bancshares, Inc. Price and Consensus

First Mid-Illinois Bancshares, Inc. price-consensus-chart | First Mid-Illinois Bancshares, Inc. Quote

Peabody Energy Corporation (BTU - Free Report) : This company that engages in coal mining business has seen the Zacks Consensus Estimate for its current year earnings increasing almost 5% over the last 60 days.Alliance Resource Partners, L.P. (ARLP - Free Report) : This company that produces and markets coal has seen the Zacks Consensus Estimate for its current year earnings increasing 8.5% over the last 60 days.

Alliance Resource Partners, L.P. Price and Consensus

 

Alliance Resource Partners, L.P. Price and Consensus

Alliance Resource Partners, L.P. price-consensus-chart | Alliance Resource Partners, L.P. Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>